View in EDS

Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study.

Saved in:
Bibliographic Details
Title: Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study.
Authors: Duffaud, Florence1 (AUTHOR) florence.duffaud@ap-hm.fr, Italiano, Antoine2 (AUTHOR), Bompas, Emannuelle3 (AUTHOR), Rios, Maria4 (AUTHOR), Penel, Nicolas5 (AUTHOR), Mir, Olivier6 (AUTHOR), Piperno-Neumann, Sophie7 (AUTHOR), Chevreau, Christine8 (AUTHOR), Delcambre, Corinne9 (AUTHOR), Bertucci, François10 (AUTHOR), Boudou-Rouquette, Pascaline11 (AUTHOR), Cancel, Mathilde12 (AUTHOR), Perrin, Christophe13 (AUTHOR), Saada-Bouzid, Esma14 (AUTHOR), Monard, Laure15 (AUTHOR), Schiffler, Camille16 (AUTHOR), Chaigneau, Loic17 (AUTHOR), Hervieu, Alice18 (AUTHOR), Collard, Olivier19 (AUTHOR), Bouvier, Corinne20 (AUTHOR)
Source: European Journal of Cancer. Jun2021, Vol. 150, p108-118. 11p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2021.03.039